Boundless Bio Valuation
| BOLD Stock | USD 1.26 0.01 0.79% |
Today, the firm appears to be overvalued. Boundless Bio Common shows a prevailing Real Value of $1.06 per share. The current price of the firm is $1.26. Our model approximates the value of Boundless Bio Common from analyzing the firm fundamentals such as Shares Owned By Insiders of 11.39 %, current valuation of (39.61 M), and Return On Equity of -0.45 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Boundless Bio's price fluctuation is dangerous at this time. Calculation of the real value of Boundless Bio Common is based on 3 months time horizon. Increasing Boundless Bio's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Boundless stock is determined by what a typical buyer is willing to pay for full or partial control of Boundless Bio Common. Since Boundless Bio is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Boundless Stock. However, Boundless Bio's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.26 | Real 1.06 | Hype 1.26 | Naive 1.27 |
The real value of Boundless Stock, also known as its intrinsic value, is the underlying worth of Boundless Bio Common Company, which is reflected in its stock price. It is based on Boundless Bio's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Boundless Bio's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Boundless Bio Common helps investors to forecast how Boundless stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Boundless Bio more accurately as focusing exclusively on Boundless Bio's fundamentals will not take into account other important factors: About Boundless Bio Valuation
The stock valuation mechanism determines Boundless Bio's current worth on a weekly basis. Our valuation model uses a comparative analysis of Boundless Bio. We calculate exposure to Boundless Bio's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Boundless Bio's related companies.Audentes Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing gene therapy products for patients living with serious, life-threatening rare diseases caused by single gene defects. Audentes Therapeutics, Inc. was founded in 2012 and is headquartered in San Francisco, California. Audentes Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 207 people.
Complementary Tools for Boundless Stock analysis
When running Boundless Bio's price analysis, check to measure Boundless Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boundless Bio is operating at the current time. Most of Boundless Bio's value examination focuses on studying past and present price action to predict the probability of Boundless Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boundless Bio's price. Additionally, you may evaluate how the addition of Boundless Bio to your portfolios can decrease your overall portfolio volatility.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |